Open Actively Recruiting

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

About

Brief Summary

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications.

Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase 3/Phase 4

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
22 Years
Maximum Age
70 Years

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
24-5045
Category
Endocrine and Metabolic Disorders
Location
  • UCLA Westwood
For Providers
NCT No.
NCT06267391
For detailed technical eligibility, visit ClinicalTrials.gov.